Leavitt Chase C.

Date	Company	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
14 Feb 24	ONCT Oncternal Therapeutics	Stock Option Common Stock	Grant	Acquire A	No	No	9.18	14,200	130.36 k	14,200
3 Jan 24	ONCT Oncternal Therapeutics	Common Stock	Payment of exercise	Dispose F	No	No	0.4961	11,838	5.87 k	84,758
2 Oct 23	ONCT Oncternal Therapeutics	Stock Option Common Stock	Grant	Acquire A	No	No	0.31	235,000	72.85 k	235,000
2 Oct 23	ONCT Oncternal Therapeutics	Stock Option Common Stock	Grant	Acquire A	No	No	0.31	210,000	65.10 k	210,000
2 Oct 23	ONCT Oncternal Therapeutics	Stock Option Common Stock	Grant	Acquire A	No	No	0.31	28,750	8.91 k	28,750
2 Oct 23	ONCT Oncternal Therapeutics	Stock Option Common Stock	Grant	Acquire A	No	No	0.31	55,519	17.21 k	55,519
2 Oct 23	ONCT Oncternal Therapeutics	Stock Option Common Stock	Grant	Acquire A	No	No	0.31	65,000	20.15 k	65,000
2 Oct 23	ONCT Oncternal Therapeutics	Stock Option Common Stock	Sale back to company	Dispose D	No	No	0.96	210,000	201.60 k	0
2 Oct 23	ONCT Oncternal Therapeutics	Stock Option Common Stock	Sale back to company	Dispose D	No	No	1.04	28,750	29.90 k	0
2 Oct 23	ONCT Oncternal Therapeutics	Stock Option Common Stock	Sale back to company	Dispose D	No	No	1.94	55,519	107.71 k	0

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.